Drug supply chain safety-fight against counterfeit drugs

Drakalska, Elena and Angelovska, Bistra and Miceva, Dijana and Sakir, Elmedina (2020) Drug supply chain safety-fight against counterfeit drugs. Knowledge - International Journal, Scientific Papers, 38. pp. 813-819. ISSN 2545-4439

Preview	Text KIJ, Vol. 38.4-1-17.pdf Download (735kB) | Preview
Preview	Text Drakalska_ANgelovska_Miceva_Sakir KNOWLEDGE 2020.03. (1) celosen.pdf Download (450kB) | Preview

Abstract

A counterfeit medication or drug is defined as a pharmaceutical product that is produced and sold with the intention to deceive the consumer about the origin, authenticity or efficacy of the product. This has the potential to be dangerous for consumers as the formulation may contain unusual ingredients or quantities of the ingredients, which can affect the effect of the medication in the body. Counterfeit drugs are a significant threat to human health and safety, as they may not be adequately tested for safety and efficacy, and may have the potential to cause harm to patients. Mislabelling can also cause patient errors or misunderstandings and is another potential for patient harm. The emergence of counterfeit drugs is a global problem due to their impact on the health of patients, the pharmaceutical industry and public health, the increasing prevalence in the world markets, both in terms of sales volume and in terms of the structure of turnover. The measures taken to tackle this problem are global and national and involve a large number of national and professional entities.

Item Type:	Article
Subjects:	Medical and Health Sciences > Other medical sciences
Divisions:	Faculty of Medical Science
Depositing User:	Elena Drakalska Sersemova
Date Deposited:	14 Jul 2020 16:07
Last Modified:	11 Dec 2024 09:40
URI:	https://eprints.ugd.edu.mk/id/eprint/24222

Actions (login required)

View Item